Molecular Nodal Restaging Based on CEACAM5, FGFR2b and PTPN11 Expression Adds No Relevant Clinical Information in Resected Non-Small Cell Lung Cancer.
Iván MacíaGemma AizaRicard RamosIgnacio EscobarFrancisco RivasAnna UreñaSamantha AsoGabriela RosadoPau Rodriguez-TaboadaCarlos DenizErnest NadalGabriel CapellaPublished in: Journal of investigative surgery : the official journal of the Academy of Surgical Research (2020)
Molecular nodal restaging based on expression levels of CEACAM5 and/or FGFR2b, does not add relevant clinical information to pathological staging of NSCLC likely related to the better prognosis of their overexpression in primary tumors.